Absci Corp (ABSI) Stock Forecast & Price Target

Absci Corp stands to benefit significantly from the rising interest in artificial intelligence applications within the biotech sector, a trend underscored by the successful investment wave in AI technologies. The company’s innovative approach to biologic drug discovery and cell line development, enabled by advanced AI tools, positions it favorably to address complex drug targets and improve therapeutic outcomes. Additionally, the successful results in clinical studies and the proven capabilities of its technology suggest a strong potential for growth within its partnered and internal programs.

Absci Corp's stock outlook is negatively impacted by the poor response rates observed in their therapies targeting solid tumors and the necessity for continuous dosing to achieve therapeutic benefits, which may decrease real-world efficacy further. The company is expected to experience volatile revenue streams that primarily rely on upfront and milestone payments, highlighting a lack of consistent revenue growth potential. Additionally, the limitations in scalability due to the slow doubling time of CHO cell lines raise concerns regarding the company's ability to efficiently ramp up production of its biologics.